Current landscape of clinical development and approval of advanced therapies-Reference-Cited by-同舟云学术

Current landscape of clinical development and approval of advanced therapies

Published:2021-12 Issue: Volume:23 Page:606-618
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Iglesias-Lopez Carolina,Agustí Antonia,Vallano Antoni,Obach Merce

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference74 articles.

1. Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States;Iglesias-Lopez;Front Pharmacol.,2019

2. Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States;Iglesias-Lopez;Cytotherapy,2021

3. Clinical trials of advanced therapy investigational medicinal products in Spain: preparing for the European clinical trials regulation;Alamo;Cell Gene Ther. Insights,2019

4. Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union;Iglesias-Lopez;Front. Pharmacol.,2021

5. Advanced therapy medicinal products: current and future perspectives;Hanna;J. Mark. Access Health Policy,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Regenerative Medicines for Rare Diseases: A Review of Industry Sponsors Investment Motivations;Therapeutic Innovation & Regulatory Science;2024-09-10

2. Strategies and delivery systems for cell-based therapy in autoimmunity;Frontiers in Drug Delivery;2024-08-08

3. Successful transport across continents of GMP-manufactured and cryopreserved culture-expanded human fetal liver-derived mesenchymal stem cells for use in a clinical trial;Regenerative Therapy;2024-06

4. EMA commentary on the guideline on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cells;British Journal of Clinical Pharmacology;2024-04-02

5. Implementation of mDoE‐methods to a microcarrier‐based expansion processes for mesenchymal stem cells;Biotechnology Progress;2024-02-09